rs16846
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000395.3(CSF2RB):c.702C>T(p.Cys234=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0357 in 1,613,734 control chromosomes in the GnomAD database, including 1,309 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.046 ( 194 hom., cov: 32)
Exomes 𝑓: 0.035 ( 1115 hom. )
Consequence
CSF2RB
NM_000395.3 synonymous
NM_000395.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0170
Genes affected
CSF2RB (HGNC:2436): (colony stimulating factor 2 receptor subunit beta) The protein encoded by this gene is the common beta chain of the high affinity receptor for IL-3, IL-5 and CSF. Defects in this gene have been reported to be associated with protein alveolar proteinosis (PAP). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 22-36929791-C-T is Benign according to our data. Variant chr22-36929791-C-T is described in ClinVar as [Benign]. Clinvar id is 226554.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36929791-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0761 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CSF2RB | NM_000395.3 | c.702C>T | p.Cys234= | synonymous_variant | 6/14 | ENST00000403662.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CSF2RB | ENST00000403662.8 | c.702C>T | p.Cys234= | synonymous_variant | 6/14 | 5 | NM_000395.3 | P1 | |
CSF2RB | ENST00000406230.5 | c.702C>T | p.Cys234= | synonymous_variant | 5/13 | 1 | |||
CSF2RB | ENST00000421539.1 | c.462C>T | p.Cys154= | synonymous_variant | 5/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0455 AC: 6926AN: 152188Hom.: 193 Cov.: 32
GnomAD3 genomes
AF:
AC:
6926
AN:
152188
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0324 AC: 8058AN: 248422Hom.: 176 AF XY: 0.0325 AC XY: 4389AN XY: 134940
GnomAD3 exomes
AF:
AC:
8058
AN:
248422
Hom.:
AF XY:
AC XY:
4389
AN XY:
134940
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0347 AC: 50686AN: 1461428Hom.: 1115 Cov.: 32 AF XY: 0.0348 AC XY: 25274AN XY: 727012
GnomAD4 exome
AF:
AC:
50686
AN:
1461428
Hom.:
Cov.:
32
AF XY:
AC XY:
25274
AN XY:
727012
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0455 AC: 6935AN: 152306Hom.: 194 Cov.: 32 AF XY: 0.0441 AC XY: 3283AN XY: 74488
GnomAD4 genome
AF:
AC:
6935
AN:
152306
Hom.:
Cov.:
32
AF XY:
AC XY:
3283
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
73
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 25, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | Cys234Cys in exon 6 of CSF2RB: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 8.0% (352/4406) of African American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs16846). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -6
Find out detailed SpliceAI scores and Pangolin per-transcript scores at